Study Details

Back
Study ID 905-CL-057
Study Title An open-label, long term, multi-center study to assess the safety andefficacy of fixed dose combinations of solifenacin succinate (6 mg and 9 mg)with tamsulosin hydrochloride OCAS 0.4 mg, in male subjects with lowerurinary tract symptoms (LUTS) associated with benign prostatichyperplasia (BPH) with a substantial storage component
Clinicaltrials.gov Identifier NCT01021332
Compound Name EC905 / solifenacin + tamsulosin
Medical Indication or Disease Lower urinary tract syndrome / Benign prostatic hyperplasia
Study Sponsor Astellas Pharma Europe B.V.
Collaborator Not Applicable
Study Start Date 26-Apr-2010
Study Completion Date 14-Dec-2011
Clinical Study Result
Select the language
English
Plain Language Summary
Select the language
English

QUICK SEARCH

USEFUL LINKS